Close Menu

Personalis

This article was originally published Oct. 23.

NEW YORK (GenomeWeb) – Personalis and the Garvan Institute of Medical Research said today that they have partnered to provide commercial human whole-genome sequencing, analysis, and interpretation services to researchers and clinicians worldwide.

NEW YORK (GenomeWeb) – Personalis has received accreditation from the College of American Pathologists for its clinical lab in Menlo Park, Calif., the genetic analysis company said today.

The Inova Translational Medicine Institute has been exploring the diagnostic use of whole-genome sequencing in newborns with unexplained syndromes in a research setting and plans to transition to a clinical diagnostic test by the end of this year.

This article has been updated to reflect the increased size of a study by Inova.

Personalis has hired Deanna Church to the position of senior director of genomics and content.

Kevin Shianna has left the New York Genome Center, where he was most recently deputy scientific director of sequencing operations.

Personalis has launched an early-access program for its "Accuracy and Content Enhanced," or ACE, Clinical Exome test to diagnose rare Mendelian disorders, which it hopes will increase the diagnostic yield of conventional diagnostic exome sequencing.

Illumina has launched its TruGenome tests, including ones for undiagnosed disease and a predisposition screen as services through its CLIA-certified and CAP-accredited laboratory.

Pages

The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.

Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.